(Press-News.org) Among adults without diabetes, quitting smoking, compared with continuing smoking, was associated with a lower risk of cardiovascular disease despite subsequent weight gain, according to a study appearing in the March 13 issue of JAMA.
"Cigarette smoking is the leading cause of preventable mortality in the United States and a major risk factor for cardiovascular disease (CVD). Smoking cessation substantially reduces the risks of CVD; however, quitting smoking is associated with a small number of adverse health consequences, weight gain being one of smokers' major concerns," according to background information in the article. The average postcessation weight gain varies between 6.6 lbs. and 13.2 lbs. in North America, happens within 6 months after smoking cessation, and persists over time. Obesity is also a risk factor for CVD. Weight gain following smoking cessation therefore might lessen the benefits of quitting smoking on CVD outcomes. In addition, among people with type 2 diabetes, weight gain following smoking cessation has potential to be of greater concern because it is a risk factor for poor diabetes control and increased risk of illness and death. "The effect on CVD of potential weight gain following smoking cessation is not well understood," the authors write.
Carole Clair, M.D., M.Sc., of the University of Lausanne, Switzerland, and colleagues conducted a study to assess the association between 4-year weight gain following smoking cessation and CVD event rate among adults with and without diabetes. The study included data from the Framingham Offspring Study collected from 1984 through 2011. At each 4-year examination, self-reported smoking status was assessed and categorized as smoker, recent quitter (≤ 4 years), long-term quitter (>4 years), and nonsmoker. Models were used to estimate the association between quitting smoking and 6-year CVD events and to test whether 4-year change in weight following smoking cessation modified the association between smoking cessation and CVD events. The primary outcome measure was the incidence over 6 years of total CVD events, comprising coronary heart disease, cerebrovascular events, peripheral artery disease, and congestive heart failure.
Weight gain occurred over 4 years in participants without and with diabetes. Among participants without diabetes, recent quitters gained significantly more weight (median [midpoint], 5.9 lbs.) than long-term quitters (1.9 lbs.), smokers (1.9 lbs.), and nonsmokers (3 lbs.). Among patients with diabetes, recent quitters also gained significantly more weight (7.9 lbs.) than smokers (1.9 lbs.), long-term quitters (0.0 lbs., and nonsmokers (1.1 lbs.).
After an average follow-up of 25 years, 631 CVD events occurred among 3,251 participants. The researchers found that among participants without diabetes, the age- and sex-adjusted CVD incidence rates were lower for nonsmokers, recent quitters, and long-term quitters, compared with smokers.
After adjustment for CVD risk factors, compared with smokers, recent quitters had a 53 percent lower risk for CVD and long-term quitters had a 54 percent lower risk for CVD; these associations had only a minimal change after further adjustment for weight change. "Among participants with diabetes, there were similar point estimates that did not reach statistical significance," the authors write.
The researchers observed similar benefits associated with smoking cessation for total CVD and for fatal and non-fatal coronary heart disease, with the cessation benefits not offset by weight gain.
"In conclusion, among adults without diabetes, quitting smoking was associated with a lower risk of CVD compared with continuing smoking. There were qualitatively similar lower risks among participants with diabetes that did not reach statistical significance, possibly because of limited study power. Weight gain that occurred following smoking cessation was not associated with a reduction in the benefits of quitting smoking on CVD risk among adults without diabetes. This supports a net cardiovascular benefit of smoking cessation, despite subsequent weight gain," the authors write.
(JAMA. 2013;309(10):1014-1021; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
There will also be a digital news release available for this study, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links. This content will be available at 3 p.m. CT Tuesday, March 12 at this link.
Editorial: Should Clinicians Encourage Smoking Cessation for Every Patient Who Smokes?
In an accompanying editorial, Michael C. Fiore, M.D., M.P.H., M.B.A., and Timothy B. Baker, Ph.D., of the University of Wisconsin School of Medicine and Public Health, Madison, suggest ways in which the findings of this study can be used by physicians.
"First, data from the study by Clair et al can be used to reassure patients concerned about the health effects of cessation-related weight gain. About 50 percent of female smokers and about 25 percent of male smokers are 'weight concerned,' which may discourage quit attempts and quitting success. Although such reassurance may not assuage concerns about the effects of weight gain on appearance, it may nevertheless be helpful. Furthermore, even though no treatments have been shown to reliably prevent cessation-related weight gain, exercise regimens may be beneficial, and use of nicotine replacement medications can suppress weight gain during their use. Second, physicians should use this information to reinforce their commitment to provide or arrange evidence based treatment for all of their patients who smoke."
(JAMA. 2013;309(10):1032-1033; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: This Editorial was supported by grants from the National Cancer Institute and National Heart, Lung, and Blood Institute. Dr. Fiore reported institutional support from Pfizer for a phase 4 study of varenicline. Dr. Baker reported no disclosures.
### END
Despite weight gain, quitting smoking associated with reduced risk of cardiovascular disease
2013-03-13
ELSE PRESS RELEASES FROM THIS DATE:
Duration of breastfeeding during infancy does not reduce a child's risk of being overweight, obese
2013-03-13
In research that included nearly 14,000 healthy infants in Belarus, an intervention that succeeded in improving the duration and exclusivity of breastfeeding during infancy did not result in a lower risk of overweight or obesity among the children at age 11.5 years, according to a study appearing in the March 13 issue of JAMA.
Observational studies suggest that greater duration and exclusivity of having been breastfed reduces child obesity risk. "However, breastfeeding and growth are socially patterned in many settings," and observed associations between these variables ...
Study examines outcomes for treatment of sleep apnea with primary care vs. specialist care
2013-03-13
Among patients who were identified as likely having moderate to severe obstructive sleep apnea, treatment based in primary care was not clinically inferior to treatment at a specialist sleep center for improvement in daytime sleepiness scores, according to a study appearing in the March 13 issue of JAMA.
"Obstructive sleep apnea with accompanying daytime sleepiness was estimated during the early 1990s to affect between 2 percent and 4 percent of middle-aged adults. With growing awareness of the public health implications of untreated disease and rising obesity rates ...
Major bleeding following PCI associated with increased risk of death
2013-03-13
In a study that included 3.3 million percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) procedures, major bleeding after PCI was associated with significantly increased in-hospital mortality, with an estimated 12 percent of deaths after PCI related to bleeding complications, according to a study appearing in the March 13 issue of JAMA.
"Bleeding represents the most common noncardiac complication of PCI. Postprocedural bleeding is associated with short- and long-term death, nonfatal ...
Weight gain after quitting smoking does not negate health benefits
2013-03-13
An analysis of data from the Framingham Offspring Study – a long-term study that follows children of participants in the original Framingham Heart Study – may have answered a question that has troubled individuals considering stopping smoking: do the health effects of any weight gained after quitting outweigh the known cardiovascular benefits of smoking cessation? The report in the March 13 issue of JAMA concludes that the benefits of stopping smoking far exceed any weight-gain associated risk.
"Among people without diabetes, those who stopped smoking had a 50 percent ...
Fertility after ectopic pregnancy: Study finds reassuring evidence on different treatments
2013-03-13
The first randomised trial to compare treatments for ectopic pregnancies has found no significant differences in subsequent fertility between medical treatment and conservative surgery on one hand, and conservative or radical surgery on the other.
The study, which is published online today (Wednesday) in Europe's leading reproductive medicine journal Human Reproduction [1], compared three ways of treating an ectopic pregnancy: medically by methotrexate injection to interrupt pregnancy in the Fallopian tube; conservative surgery, which preserves the Fallopian tube (known ...
Researchers find link between low cognitive score and risk of brain injury
2013-03-13
It is estimated that there are 10 million cases of traumatic brain injury globally every year with mild traumatic brain injuries being responsible for 70-90% of these. Incidence is highest among young males.
Current literature suggests that mild traumatic brain injuries cause changes in brain tissues and have important long-term consequences on cognitive function. Deficits have been described in attention, memory, verbal learning and processing speed and may occur in 15-25% of those suffering one of these injuries.
However, little is known about population-wide cognitive ...
When hungry, Gulf of Mexico algae go toxic
2013-03-13
When Gulf of Mexico algae don't get enough nutrients, they focus their remaining energy on becoming more and more poisonous to ensure their survival, according to a new study by scientists from North Carolina State University and the National Oceanic and Atmospheric Administration.
The study shows that harmful and ubiquitous Karenia brevis algae, which cause red tide blooms across the Gulf of Mexico, become two to seven times more toxic when levels of phosphorus, a major algal nutrient found in fertilizers and human waste, are low. Like wearing a suit of armor, producing ...
Marine diversity study proves value of citizen science
2013-03-13
Citizen science surveys compare well with traditional scientific methods when it comes to monitoring species biodiversity – according to new research from the University of East Anglia.
Research published today in the journal Methods in Ecology and Evolution shows that methods to record marine diversity used by amateurs returned results consistent with techniques favoured by peer-reviewed science.
The findings give weight to the growing phenomenon of citizen science, which sees data crowd-sourced from an army of avid twitchers, divers, walkers and other wildlife enthusiasts. ...
'I don't want to pick!' Preschoolers know when they aren't sure
2013-03-13
Children as young as 3 years old know when they are not sure about a decision, and can use that uncertainty to guide decision making, according to new research from the Center for Mind and Brain at the University of California, Davis.
"There is behavioral evidence that they can do this, but the literature has assumed that until late preschool, children cannot introspect and make a decision based on that introspection," said Simona Ghetti, professor of psychology at UC Davis and co-author of the study with graduate student Kristen Lyons, now an assistant professor at Metropolitan ...
Promising new drug treats and protects against radiotherapy-associated oral mucositis
2013-03-13
Mouse model studies show that administered genetically or topically, protein Smad7 protects against or heals mouth sores commonly associated with cancer treatment.
In some cancer patients treated with radiation, the mouth sores known as oral mucositis become so severe that feeding tubes are required for nutrition and narcotics are needed for pain. In fact, 40-70 percent of patients treated with upper-body radiation develop the condition to some degree. Currently, there is no FDA approved treatment. A University of Colorado Cancer Center study published this week in the ...